Quantcast

Latest Inhaler Stories

2010-06-02 18:17:00

WILMINGTON, Del., June 2 /PRNewswire-FirstCall/ -- Today, the U.S. Food and Drug Administration (FDA) released final label revisions for respiratory medications that contain an active ingredient known as a long-acting beta-agonist (LABA).

2010-05-18 08:15:00

REDWOOD CITY, Calif., May 18 /PRNewswire/ -- Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, presented results from four studies that provide support for further development of PT003, the company's fixed dose combination of glycopyrrolate and formoterol delivered via a pressurized hydrofluoroalkane metered dose inhaler (HFA-MDI).

2010-05-17 08:00:00

REDWOOD CITY, Calif., May 17 /PRNewswire/ -- Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, has been named a TiE50 Winner in the BioSciences category, as a leader in innovation, ingenuity and management excellence.

2010-05-05 07:00:00

REDWOOD CITY, Calif., May 5 /PRNewswire/ -- Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced four upcoming poster presentations at the Annual Meeting of the American Thoracic Society (ATS) to be held at the Ernest N.

2010-04-29 13:36:00

PHILADELPHIA, April 29 /PRNewswire/ -- In the United States alone, over 22 million people, including more than six million children, are known to have asthma, which is a leading cause of hospital emergency department visits and school absenteeism.

2010-04-26 08:45:00

WALTHAM, Mass., April 26 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite increased competition from several emerging agents, GlaxoSmithKline's Advair will remain surveyed pulmonologists' and primary care physicians' (PCPs) favored fixed-dose long-acting beta2 agonist (LABA)/inhaled corticosteroid (ICS) combination inhaler through 2013 for the treatment of asthma and chronic obstructive...

2010-04-13 17:12:00

RIDGEFIELD, Conn., April 13 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that the U.S.

2010-04-13 12:59:00

SILVER SPRING, Md., April 13 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S.

2010-04-13 12:49:00

SILVER SPRING, Md., April 13 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) says that seven metered dose inhalers that contain chlorofluorocarbons (CFCs) are being phased out in the United States. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) These inhalers use CFCs as propellants to spray the medicine out of the inhaler so patients can breathe the medicine into their lungs.


Word of the Day
megalophonous
  • Having a loud voice; vociferous; clamorous.
  • Of grand or imposing sound.
The word 'megalophonous' comes from Greek roots meaning 'big' and 'sound'.